对于膀癌患者的内皮相关预后指数
Deng-Xiong Li1, Rui-Cheng Wu1, Jie Wang1
1Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Discover oncology
|April 25, 2024
概括
我们开发了一个内皮相关预后指数 (EPI),使用基因表达数据来预测膀癌患者的结果. EPI识别了可能对免疫疗法或化疗有反应的患者,帮助精准医学.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 内皮细胞在瘤微环境中显著影响膀癌 (BC) 的预后.
- 了解内皮细胞的影响对于改善BC患者的治疗结果至关重要.
研究的目的:
- 阐明内皮细胞对膀癌患者结局的影响.
- 开发基于内皮细胞相关基因的预后指数.
主要方法:
- 从在线数据库中集成的单细胞和批量RNA测序数据.
- 使用R版本3.6.3来开发和验证内皮相关预后指数 (EPI).
主要成果:
- 制定了一个EPI,包括六个具有显著预后价值的基因 (CYTL1,FAM43A,GSN,HSPG2,RBP7,SLC2A3).
- EPI与内皮细胞功能和免疫过程相关,预测免疫治疗反应 (低风险) 和化疗敏感性 (高风险).
- 在癌症基因组图谱 (TCGA) 和外部数据集中验证了EPI.
结论:
- 鉴定出关键的内皮细胞相关基因,用于膀癌的预后.
- 为膀癌患者开发了一种新的EPI,支持精准医学策略.
相关概念视频
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


